111 related articles for article (PubMed ID: 3499924)
1. Electrophysiological action of bepridil on atrioventricular accessory pathways.
Touboul P; Atallah G; Kirkorian G; Lavaud P; Kieny JR; Mathieu MP; Dellinger A
Br Heart J; 1987 Oct; 58(4):333-8. PubMed ID: 3499924
[TBL] [Abstract][Full Text] [Related]
2. Effects of intravenous sotalol in patients with atrioventricular accessory pathways.
Touboul P; Atallah G; Kirkorian G; Lavaud P; Mathieu MP; Dellinger A
Am Heart J; 1987 Sep; 114(3):545-50. PubMed ID: 3630895
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy and electrophysiologic effects of encainide in patients with Wolff-Parkinson-White syndrome.
Prystowsky EN; Klein GJ; Rinkenberger RL; Heger JJ; Naccarelli GV; Zipes DP
Circulation; 1984 Feb; 69(2):278-87. PubMed ID: 6418407
[TBL] [Abstract][Full Text] [Related]
4. Electrophysiologic effects of lorcainide on the accessory pathway in the Wolff-Parkinson-White syndrome.
Kasper W; Treese N; Meinertz T; Jähnchen E; Pop T
Am J Cardiol; 1983 Jun; 51(10):1618-22. PubMed ID: 6858867
[TBL] [Abstract][Full Text] [Related]
5. The electrophysiologic effects of volatile anesthetics and sufentanil on the normal atrioventricular conduction system and accessory pathways in Wolff-Parkinson-White syndrome.
Sharpe MD; Dobkowski WB; Murkin JM; Klein G; Guiraudon G; Yee R
Anesthesiology; 1994 Jan; 80(1):63-70. PubMed ID: 8291732
[TBL] [Abstract][Full Text] [Related]
6. Effect of atropine and isoproterenol on tachycardia induction in asymptomatic patients with Wolff-Parkinson-White electrocardiographic pattern.
Kim YH; Leitch JW; Klein GJ; Yee R; Leather RA
Can J Cardiol; 1992 Sep; 8(7):716-20. PubMed ID: 1422992
[TBL] [Abstract][Full Text] [Related]
7. [Electrophysiologic properties of cibenzoline in Wolff-Parkinson-White syndrome and atrioventricular nodal reentry tachycardia].
Kühlkamp V; Ickrath O; Schmid F; Mayer F; Haasis R; Seipel L
Z Kardiol; 1989 Oct; 78(10):640-6. PubMed ID: 2686251
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiologic and antiarrhythmic actions of bepridil. Comparison with verapamil and ajmaline for atrioventricular reentrant tachycardia.
Rowland E; McKenna WJ; Krikler DM
Am J Cardiol; 1985 Jun; 55(13 Pt 1):1513-9. PubMed ID: 3873867
[TBL] [Abstract][Full Text] [Related]
9. Encainide for treatment of atrioventricular reciprocating tachycardia in the Wolff-Parkinson-White syndrome.
Miles WM; Zipes DP; Rinkenberger RL; Markel ML; Prystowsky EN; Dougherty AH; Heger JJ; Naccarelli GV
Am J Cardiol; 1988 Dec; 62(19):20L-25L. PubMed ID: 3144163
[TBL] [Abstract][Full Text] [Related]
10. Flecainide in the Wolff-Parkinson-White syndrome.
Crozier I
Am J Cardiol; 1992 Aug; 70(5):26A-32A. PubMed ID: 1509995
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiologic and antiarrhythmic properties of bepridil.
Prystowsky EN
Am J Cardiol; 1985 Mar; 55(7):59C-62C. PubMed ID: 3872056
[TBL] [Abstract][Full Text] [Related]
12. Effect of propafenone in the Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up.
Breithardt G; Borggrefe M; Wiebringhaus E; Seipel L
Am J Cardiol; 1984 Nov; 54(9):29D-39D. PubMed ID: 6496367
[TBL] [Abstract][Full Text] [Related]
13. [The electrophysiologic effects of intravenously administered bepridil].
Ponsonnaille J; Citron B; Threil F; Heiligenstein D; Gras H
Arch Mal Coeur Vaiss; 1982 Dec; 75(12):1415-23. PubMed ID: 6820263
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiologic mechanisms of adverse effects of class I antiarrhythmic drugs (cibenzoline, pilsicainide, disopyramide, procainamide) in induction of atrioventricular re-entrant tachycardia.
Fujiki A; Tani M; Yoshida S; Inoue H
Cardiovasc Drugs Ther; 1996 May; 10(2):159-66. PubMed ID: 8842508
[TBL] [Abstract][Full Text] [Related]
15. [Clinical electrophysiologic effects of lorcainide in patients and its effect on the conduction of accessory pathway in Wolff-Parkinson-White syndrome].
Jiang H
Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Jun; 18(3):157-9, 190. PubMed ID: 2086169
[TBL] [Abstract][Full Text] [Related]
16. Beta-blocker therapy for the Wolff-Parkinson-White syndrome.
Prystowsky EN; Greer S; Packer DL; Thompson KA; German LD
Am J Cardiol; 1987 Aug; 60(6):46D-50D. PubMed ID: 2888300
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiologic effects of bepridil in the anesthetized dog studied by endocardiac electrodes.
Sassine A; Masse C; Fajuri A; Hirsch JL; Labrid C; Puech P
Am J Cardiol; 1984 Jun; 53(11):1707-11. PubMed ID: 6610347
[TBL] [Abstract][Full Text] [Related]
18. 'Dual atrioventricular nodal pathways" in patients with Wolff-Parkinson-White syndrome.
Pritchett EL; Prystowsky EN; Benditt DG; Gallagher JJ
Br Heart J; 1980 Jan; 43(1):7-13. PubMed ID: 7356864
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of supraventricular and paroxysmal ventricular tachycardia with bepridil].
Fauchier JP; Cosnay P; Néel C; Rouesnel P; Bonnet P; Quilliet L
Arch Mal Coeur Vaiss; 1985 Apr; 78(4):612-9. PubMed ID: 3923987
[TBL] [Abstract][Full Text] [Related]
20. [Effects of oral and injectable flecainide in patients with an accessory atrioventricular pathway].
Fauchier JP; Cosnay P; Rouesnel P; Moquet B; Bonnet P; Scala PJ; Demeyer JF
Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():81-90. PubMed ID: 3938264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
